Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.
The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...
The event raised awareness for those with lupus, a chronic autoimmune disease that leads the body’s immune system to attack ...
The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...
Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...
Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is ...
Severe presentations of skin aGVHD involving rapid progression of rash to bullae formation and mucosal involvement are rare. There are reports of patients with skin aGVHD that present with clinical ...
It’s a bird, it’s a plane, it’s Super Sub! U-Boat Worx’s just-launched, ruby-red flagship may have more in common with the original 1950s Superman than the color of his cape. The Dutch ...
BACKGROUND: Nearly 10% of lupus erythematosus (LE ... terbinafine for a suspected dermatophytic infection developed a subacute cutaneous LE, within 7 weeks following terbinafine introduction.
Bristol-Myers Squibb (BMS) is a specialty biopharmaceutical company. It is engaged in the discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related ...
Itolizumab is under clinical development by Equillium and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% ...
Chronic lymphocytic leukemia (CLL) starts in bone marrow, the soft inner part of your bones. There are some key differences that set CLL apart from other types of leukemia, such as ALL (acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results